Seattle Genetics Inc (NASDAQ:SGEN)

36.22
Delayed Data
As of Mar 27
 +0.50 / +1.40%
Today’s Change
30.05
Today|||52-Week Range
47.67
+12.73%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close35.72
Today’s open35.71
Day’s range35.47 - 36.44
Volume827,808
Average volume (3 months)1,211,031
Market cap$4.5B
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-14.72%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book21.30

Competitors

 Today’s
change
Today’s
% change
RCPTReceptos Inc+8.44+6.07%
GRFSGrifols SA+0.69+2.13%
AKRXAkorn Inc+2.21+4.78%
NBIXNeurocrine Bioscienc...+1.45+3.88%
Data as of 4:00pm ET, 03/27/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account